Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
Development of selective kinase inhibitors remains a challenge due to considerable amino acid sequence similarity among family members particularly in the ATP binding site. Targeting the activation loop might offer improved inhibitor selectivity since this region of kinases is less conserved. Howeve...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2018
|
| _version_ | 1826281042014633984 |
|---|---|
| author | Suebsuwong, C Pinkas, D Ray, S Bufton, J Dai, B Bullock, A Degterev, A Cuny, G |
| author_facet | Suebsuwong, C Pinkas, D Ray, S Bufton, J Dai, B Bullock, A Degterev, A Cuny, G |
| author_sort | Suebsuwong, C |
| collection | OXFORD |
| description | Development of selective kinase inhibitors remains a challenge due to considerable amino acid sequence similarity among family members particularly in the ATP binding site. Targeting the activation loop might offer improved inhibitor selectivity since this region of kinases is less conserved. However, the strategy presents difficulties due to activation loop flexibility. Herein, we report the design of receptor-interacting protein kinase 2 (RIPK2) inhibitors based on pankinase inhibitor regorafenib that aim to engage basic activation loop residues Lys169 or Arg171. We report development of CSR35 that displayed > 10-fold selective inhibition of RIPK2 versus VEGFR2, the target of regorafenib. A co-crystal structure of CSR35 with RIPK2 revealed a resolved activation loop with an ionic interaction between the carboxylic acid installed in the inhibitor and the side-chain of Lys169. Our data provides principle feasibility of developing activation loop targeting type II inhibitors as a complementary strategy for achieving improved selectivity. |
| first_indexed | 2024-03-07T00:22:49Z |
| format | Journal article |
| id | oxford-uuid:7d1fe982-ea2a-4f19-80a7-864776281081 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:22:49Z |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:7d1fe982-ea2a-4f19-80a7-8647762810812022-03-26T21:01:30ZActivation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitorsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7d1fe982-ea2a-4f19-80a7-864776281081Symplectic Elements at OxfordElsevier2018Suebsuwong, CPinkas, DRay, SBufton, JDai, BBullock, ADegterev, ACuny, GDevelopment of selective kinase inhibitors remains a challenge due to considerable amino acid sequence similarity among family members particularly in the ATP binding site. Targeting the activation loop might offer improved inhibitor selectivity since this region of kinases is less conserved. However, the strategy presents difficulties due to activation loop flexibility. Herein, we report the design of receptor-interacting protein kinase 2 (RIPK2) inhibitors based on pankinase inhibitor regorafenib that aim to engage basic activation loop residues Lys169 or Arg171. We report development of CSR35 that displayed > 10-fold selective inhibition of RIPK2 versus VEGFR2, the target of regorafenib. A co-crystal structure of CSR35 with RIPK2 revealed a resolved activation loop with an ionic interaction between the carboxylic acid installed in the inhibitor and the side-chain of Lys169. Our data provides principle feasibility of developing activation loop targeting type II inhibitors as a complementary strategy for achieving improved selectivity. |
| spellingShingle | Suebsuwong, C Pinkas, D Ray, S Bufton, J Dai, B Bullock, A Degterev, A Cuny, G Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors |
| title | Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors |
| title_full | Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors |
| title_fullStr | Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors |
| title_full_unstemmed | Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors |
| title_short | Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors |
| title_sort | activation loop targeting strategy for design of receptor interacting protein kinase 2 ripk2 inhibitors |
| work_keys_str_mv | AT suebsuwongc activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors AT pinkasd activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors AT rays activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors AT buftonj activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors AT daib activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors AT bullocka activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors AT degtereva activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors AT cunyg activationlooptargetingstrategyfordesignofreceptorinteractingproteinkinase2ripk2inhibitors |